Vitamin D & endothelial function

Indian Journal of Medical Research

Volumn 140, Issue October, 2014, Pages 483-490

  Alyami, A ^a   Soares, Mario J ^a   Sherriff, J L ^a   Mamo, J C ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Endothelial function; Flow mediated dilatation; Inflammation; Obesity; Supplementation; Vitamin D

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIFEDIOL; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPITHELIAL CELL ADHESION MOLECULE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; JUNCTIONAL ADHESION MOLECULE B; LEPTIN; MYELOPEROXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGENASE; PADGEM PROTEIN; PHOSPHOLIPASE A2; PLASMA PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROSTACYCLIN; SCATTER FACTOR; THROMBOCYTE ACTIVATION INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITAMIN D;

BLOOD VESSEL REACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL FUNCTION; ENZYME ACTIVITY; HUMAN; OUTCOME ASSESSMENT; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VASCULITIS; VASODILATATION; VITAMIN SUPPLEMENTATION; DIABETES MELLITUS, TYPE 2; DIET SUPPLEMENTATION; DRUG EFFECTS; ENDOTHELIUM; GENETICS; INSULIN RESISTANCE; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; ENDOTHELIUM; HUMANS; INSULIN RESISTANCE; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; VITAMIN D;

EID: 84913529028     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Misra A, Chowbey P, Makkar B, Vikram N, Wasir J, Chadha D, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physcians India 2009; 57: 163-70.
2. Harinarayan CV, Ramalakshmi T, Prasad UV, Sudhakar D, Srinivasarao PV, Sarma KV, et al. High prevalence of low dietary calcium, high phytate consumption, and vitamin D deficiency in healthy south Indians. Am J Clin Nutr 2007; 85: 1062-7.
3. Sachan A, Gupta R, Das V, Agarwal A, Awasthi PK, Bhatia V. High prevalence of vitamin D deficiency among pregnant women and their newborns in northern India. Am J Clin Nutr 2005; 81: 1060-4.
4. Goswami R, Marwaha RK, Gupta N, Tandon N, Sreenivas V, Tomar N, et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr 2009; 102: 382-6.
5. Nowson CA, McGrath JJ, Ebeling PR, Haikerwal A, Daly RM, Sanders KM, et al. Vitamin D and health in adults in Australia and New Zealand: a position statement. Med J Aust 2012; 196: 686-7.
6. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-8.
7. Soares MJ, Pathak K, Calton EK. Calcium and vitamin D in the regulation of energy balance: where do we stand? Int J Mol Sci 2014; 15: 4938-45.
8. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080S-6S.
9. Peterlik M, Cross H. Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology. Eur J Clin Nutr 2009; 63: 1377-86.
10. Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008; 3: 1535-41.
11. Szmitko PE, Wang C-H, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New markers of inflammation and endothelial cell activation part I. Circulation 2003; 108: 1917-23.
12. Sandoo A, van Zanten JJV, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J 2010; 4: 302.
13. Johns DG, Charpie JR, Webb RC. Is ceramide signaling a target for vascular therapeutic intervention? Curr Pharma Design 1998; 4: 481-8.
14. Pasimeni G, Ribaudo MC, Capoccia D, Rossi F, Bertone C, Leonetti F, et al. Non-invasive evaluation of endothelial dysfunction in uncomplicated obesity: Relationship with insulin resistance. Microvasc Res 2006; 71: 115-20.
15. Tousoulis D, Antoniades C, Stefanadis C. Evaluating endothelial function in humans: a guide to invasive and noninvasive techniques. Heart 2005; 91: 553-8.
16. Smith S, Greenland P, Grundy S. American Heart Association Conference Proceedings, Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention. Executive summary. Circulation 2000; 10: E12-6.
17. Barac A, Campia U, Panza JA. Methods for evaluating endothelial function in humans. Hypertenion 2007; 49: 748-60.
18. Woodman R, Watts G. Measurement and application of arterial stiffness in clinical research: focus on new methodologies and diabetes mellitus. Med Sci Monitor 2003; 9: RA81-RA89.
19. Soares MJ, Kuriyan R, Kurpad AV. Calcium and vitamin D modulate postprandial vascular function: A pilot dose-response study. Diab Met Syn: Clin Res Rev 2010; 4: 128-31.
20. Huang AL, Vita JA. Effects of systemic inflammation on endothelium-dependent vasodilation. Trends Cardiovas Med 2006; 16: 15-20.
21. Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ. Hemostatic function and progressing ischemic stroke D-dimer predicts early clinical progression. Stroke 2004; 35: 1421-5.
22. Meigs JB, Hu FB, Rifai N, Manson JE. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004; 291: 1978-86.
23. Zhang R, Brennan M-L, Fu X, Aviles RJ, Pearce GL, Penn MS, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286: 2136-42.
24. Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001; 103: 491-5.
25. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-34.
26. Reinhart K, Bayer O, Brunkhorst F, Meisner M. Markers of endothelial damage in organ dysfunction and sepsis. Crit Care Med 2002; 30: S302-S12.
27. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220.
28. Ren J. Leptin and hyperleptinemia-from friend to foe for cardiovascular function. J Endocrinol 2004; 181: 1-10.
29. Yasuda S, Goto Y, Baba T, Satoh T, Sumida H, Miyazaki S, et al. Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function. J Am Coll Cardiol 2000; 36: 115-21.
30. Zhang H, Park Y, Wu J, Chen X, Lee S, Yang J, et al. Role of TNF-alpha in vascular dysfunction. Clin Sci 2009; 116: 219-30.
31. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, et al. Synthesis of 1, 25-dihydroxyvitamin D3 by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephr 2002; 13: 621-9.
32. Lai Y-H, Fang T-C. The pleiotropic effect of Vitamin D. ISRN Nephr 2013; Article ID898125: 6 pages. Available from: http://dx.doi.org/10.5402/2013/898125, accessed March 28, 2014.
33. Verdoia M, Schaffer A, Sartori C, Barbieri L, Cassetti E, Marino P, et al. Vitamin D deficiency is independently associated with the extent of coronary artery disease. Eur J Clin Invest 2014; 44: 634-42.
34. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Contr Clin Trials 1996; 17: 1-12.
35. Yiu YF, Yiu KH, Siu CW, Chan YH, Li SW, Wong LY, et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013; 227: 140-6.
36. Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N, Stein JH. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One 2012; 7: e36617.
37. Harris RA, Pedersen-White J, Guo DH, Stallmann-Jorgensen IS, Keeton D, Huang Y, et al. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 2011; 24: 557-62.
38. Sokol SI, Srinivas V, Crandall JP, Kim M, Tellides G, Lebastchi AH, et al. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. VascMed 2012; 17: 394-404.
39. Stricker H, Tosi Bianda F, Guidicelli-Nicolosi S, Limoni C, Colucci G. Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. Eur J Vasc Endovasc Surg 2012; 44: 307-12.
40. Witham MD, Adams F, Kabir G, Kennedy G, Belch JJ, Khan F. Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK- a randomised controlled trial. Atherosclerosis 2013; 230: 293-9.
41. Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetoliga 2010; 53: 2112-9.
42. Witham MD, Dove FJ, Khan F, Lang CC, Belch JJ, Struthers AD. Effects of vitamin D supplementation on markers of vascular function after myocardial infarction- a randomised controlled trial. Int J Cardiol 2013; 167: 745-9.
43. Witham MD, Dove FJ, Sugden JA, Doney AS, Struthers AD. The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 2012; 22: 864-70.
44. Witham MD, Price RJ, Struthers AD, Donnan PT, Messow CM, Ford I, et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med 2013; 173: 1672-9.
45. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-6.
46. Vieth R. What is the optimal vitamin D status for health? Prog Biophys Mol Bio 2006; 92: 26-32.
47. Pathak K, Soares M, Calton E, Zhao Y, Hallett J. Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 2014; 15: 528-37.
48. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. Br J Nutr 2010; 103: 549-55.